Biotechnology in the United States

Biotechnology in the United States

Code: ML-OHME4729 | Published: Jan-2016 | Pages: 37 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The US biotechnology market is expected to generate total revenues of $147.0bn in 2015, representing a compound annual growth rate (CAGR) of 12% between 2011 and 2015.

- The medical/healthcare segment is expected to be the markets most lucrative in 2015, with total revenues of $86.5bn, equivalent to 58.9% of the markets overall value.

- Leading US companies operating specifically in the biotechnology sector (such as Gilead Sciences, Amgen, Biogen and Celgene) have grown market capitalizations significantly in recent years, fuelled by speculation that the industry is making real progress towards successful medical advances.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States

Leading company profiles reveal details of key biotechnology market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the United States economy

Reasons To Buy
What was the size of the United States biotechnology market by value in 2015?

What will be the size of the United States biotechnology market in 2020?

What factors are affecting the strength of competition in the United States biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up the United Statess biotechnology market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Amgen, Inc. 20
Baxter International Inc. 23
Biogen, Inc. 26
Merck and Co., Inc. 29
Macroeconomic Indicators 32
Country Data 32
Methodology 34
Industry associations 35
Related MarketLine research 35
Appendix 36
About MarketLine 36

List of Tables
Table 1: United States biotechnology industry value: $ billion, 2011-15(e)
Table 2: United States biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: United States biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: United States biotechnology industry value forecast: $ billion, 2015-20
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Baxter International Inc.: key facts
Table 9: Baxter International Inc.: key financials ($)
Table 10: Baxter International Inc.: key financial ratios
Table 11: Biogen, Inc.: key facts
Table 12: Biogen, Inc.: key financials ($)
Table 13: Biogen, Inc.: key financial ratios
Table 14: Merck and Co., Inc.: key facts
Table 15: Merck and Co., Inc.: key financials ($)
Table 16: Merck and Co., Inc.: key financial ratios
Table 17: United States size of population (million), 2011-15
Table 18: United States gdp (constant 2005 prices, $ billion), 2011-15
Table 19: United States gdp (current prices, $ billion), 2011-15
Table 20: United States inflation, 2011-15
Table 21: United States consumer price index (absolute), 2011-15
Table 22: United States exchange rate, 2011-15

List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2011-15(e)
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: United States biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2015
Figure 11: Amgen, Inc.: revenues and profitability
Figure 12: Amgen, Inc.: assets and liabilities
Figure 13: Baxter International Inc.: revenues and profitability
Figure 14: Baxter International Inc.: assets and liabilities
Figure 15: Biogen, Inc.: revenues and profitability
Figure 16: Biogen, Inc.: assets and liabilities
Figure 17: Merck and Co., Inc.: revenues and profitability
Figure 18: Merck and Co., Inc.: assets and liabilities
Amgen, Inc., Baxter International Inc., Biogen, Inc., Merck and Co., Inc.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Biotechnology
MarketLine